ID: ALA3695591

Max Phase: Preclinical

Molecular Formula: C28H25Cl2N7O4

Molecular Weight: 594.46

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CC(C)(C)c1cc(NC(=O)Nc2ccc(Oc3ccnc4[nH]c(=O)cnc34)c(Cl)c2Cl)n(-c2ccc(CO)cc2)n1

Standard InChI:  InChI=1S/C28H25Cl2N7O4/c1-28(2,3)20-12-21(37(36-20)16-6-4-15(14-38)5-7-16)34-27(40)33-17-8-9-18(24(30)23(17)29)41-19-10-11-31-26-25(19)32-13-22(39)35-26/h4-13,38H,14H2,1-3H3,(H,31,35,39)(H2,33,34,40)

Standard InChI Key:  FEFIXEMJIYHFAZ-UHFFFAOYSA-N

Associated Targets(Human)

MAP kinase p38 gamma 2776 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Tyrosine-protein kinase HCK 2743 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Tyrosine-protein kinase SRC 10310 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

MAP kinase p38 alpha 12866 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 594.46Molecular Weight (Monoisotopic): 593.1345AlogP: 6.04#Rotatable Bonds: 6
Polar Surface Area: 147.05Molecular Species: NEUTRALHBA: 8HBD: 4
#RO5 Violations: 2HBA (Lipinski): 11HBD (Lipinski): 4#RO5 Violations (Lipinski): 3
CX Acidic pKa: 10.62CX Basic pKa: 3.97CX LogP: 5.83CX LogD: 5.83
Aromatic Rings: 5Heavy Atoms: 41QED Weighted: 0.19Np Likeness Score: -1.26

References

1.  (2015)  Respiratory formulations and compounds for use therein, 

Source

Source(1):